EO Residuals Testing
Every EO-sterilized device must demonstrate that residual EO, ethylene chlorohydrin (ECH), and ethylene glycol (EG) meet the patient-contact thresholds in ISO 10993-7. Boulder BioLabs executes EO residuals testing protocols aligned with ISO 10993-7 using headspace and exhaustive extraction GC methods, operating under the Boulder BioMed ISO 13485 quality management system.
What Is EO Residuals Testing?
Ethylene oxide kills microorganisms by alkylating DNA but is toxic at residual levels, and reacts with chlorides to form ECH or with water to form EG. ISO 10993-7 sets maximum residuals for EO, ECH, and EG based on patient contact duration (limited, prolonged, permanent) and route (skin, mucosa, blood, implant).
We run both major extraction strategies: headspace (approximates patient gas exposure) and exhaustive (total residual load). Analysis is by gas chromatography with flame ionization detection (GC-FID).
When Required
- Initial EO sterilization validation — aligned with ISO 11135.
- Annual revalidation per ISO 11135 §12.
- Design changes — materials, packaging, density, geometry.
- Cycle changes — aeration time, temperature, EO concentration.
- New materials — polymers, adhesives, coatings.
- Post-recall remediation.
The Strongest Integration Story
The EO cycle has a back-end called aeration, where residual EO out-gasses. National labs typically don't see the device until 2–5 business days after aeration ends — that shipping window adds extra aeration time onto the sample. When EO residuals testing happens on the same campus as the EO sterilizer, the sample is pulled at the moment aeration ends. Cycles tighten. Throughput climbs. Validations finish in days that used to take weeks.